Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators
Gisele Nishiguchi, Fatemeh Keramatnia, Jaeki Min, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7296-7311
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic
Janet M. Sasso, Rumiana Tenchov, Dasheng Wang, et al.
Biochemistry (2022) Vol. 62, Iss. 3, pp. 601-623
Open Access | Times Cited: 112
Rational Chemical Design of Molecular Glue Degraders
Ethan S. Toriki, James W. Papatzimas, Kaila Nishikawa, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 915-926
Open Access | Times Cited: 94
E3 ligase ligand chemistries: from building blocks to protein degraders
Izidor Sosič, Aleša Bricelj, Christian Steinebach
Chemical Society Reviews (2022) Vol. 51, Iss. 9, pp. 3487-3534
Closed Access | Times Cited: 92
From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation
Vladas Oleinikovas, Pablo Gaínza, Thomas Ryckmans, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 291-312
Open Access | Times Cited: 60
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 58
Targeted protein degrader development for cancer: advances, challenges, and opportunities
Yuan Fang, Shuhang Wang, Songzhe Han, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 5, pp. 303-317
Open Access | Times Cited: 48
Targeting the undruggables—the power of protein degraders
Chao Zhang, Yongbo Liu, Guangchen Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 11, pp. 1776-1797
Open Access | Times Cited: 20
Ligandability of E3 Ligases for Targeted Protein Degradation Applications
Bridget P. Belcher, Carl C. Ward, Daniel K. Nomura
Biochemistry (2021) Vol. 62, Iss. 3, pp. 588-600
Open Access | Times Cited: 97
Phenyl‐Glutarimides: Alternative Cereblon Binders for the Design of PROTACs
Jaeki Min, Anand Mayasundari, Fatemeh Keramatnia, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 51, pp. 26663-26670
Open Access | Times Cited: 92
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective
Xin Han, Wenyi Wei, Yi Sun
Acta Materia Medica (2022) Vol. 1, Iss. 2
Open Access | Times Cited: 47
Protein–protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction
Huan Rui, Kate S. Ashton, Jaeki Min, et al.
RSC Chemical Biology (2023) Vol. 4, Iss. 3, pp. 192-215
Open Access | Times Cited: 41
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design
Jamie Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 2, pp. 141-145
Open Access | Times Cited: 37
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 28
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines
Gisele Nishiguchi, Lauren G. Mascibroda, Sarah M. Young, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Innovative, combinatorial and high-throughput approaches to degrader synthesis
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 10
Clues to molecular glues
Thomas Geiger, Sabine C. Schäfer, Johannes K. Dreizler, et al.
Current Research in Chemical Biology (2021) Vol. 2, pp. 100018-100018
Open Access | Times Cited: 44
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Hongyu Wu, Hong Yao, Chen He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3548-3566
Open Access | Times Cited: 29
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Miquel Duran‐Frigola, Marko Cigler, Georg E. Winter
Journal of the American Chemical Society (2023) Vol. 145, Iss. 5, pp. 2711-2732
Open Access | Times Cited: 21
Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges?
Marcin Cieślak, Marta Słowianek
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 812-812
Open Access | Times Cited: 21
Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives
Radosław P. Nowak, Jianwei Che, Silas Ferrao, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 3, pp. 501-506
Closed Access | Times Cited: 20
Lenalidomide Stabilizes Protein–Protein Complexes by Turning Labile Intermolecular H-Bonds into Robust Interactions
Marina Miñarro-Lleonar, Andrea Bertran-Mostazo, Jorge Duro, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6037-6046
Open Access | Times Cited: 17
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs
Christian Steinebach, Aleša Bricelj, Arunima Murgai, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14513-14543
Open Access | Times Cited: 17
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3
Yuying Suo, Daohai Du, Chao Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4804-4818
Closed Access | Times Cited: 7
Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs
Lisa J. Alcock, Yunchao Chang, Jamie Jarusiewicz, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 3, pp. 475-482
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top